It often looks like Walgreen has a drug store on every corner in the valley but the profits came home to roost yesterday when the company announced a 5 percent jump in profit. The boost came mainly from the sale of generic drugs, reports the Associated Press.

The company said it earned $345.6 million in the three months ended Nov. 30, up from $328.6 million a year earlier. Excluding the expensing of stock options, Walgreen said it would have earned 36 cents a share.

Of course, the old earnings numbers used to come with a calculation of profits if options had been expensed buried deep in the back. Now, the reports are coming out with a comparison to show how the numbers stack up against recent years when options did not have to be counted as a debit on the balance sheet.

Revenue at the company, which is the nation’s largest drugstore chain in terms of sales, grew 10 percent, to $10.9 billion. Sales at stores open at least a year increased 7.2 percent for the period.

And so we’ll probably see a few more of those stores in Southern Nevada.